Consequently, the findings pertaining to the role of the piR-31115/METTL3/YAP1/IGF2BP2 signalling pathway in tumour angiogenesis may not be directly applicable to all TNBC cases or other breast cancer types. This evidence concerns the gene METTL3 and breast cancer.